BirchBioMed Inc. is a commercialization-based biotech company
focused on the clinical evaluation and development of proprietary anti-scarring drugs,
autoimmune therapeutics/therapies and novel strategies for transplantation.

 

For further information, including investor inquires and corporate affairs, contact:

Susan Elliott
CFO & CMO
905.833.0826
susan.elliott@birchbiomed.com